ACRS
Aclaris Therapeutics, Inc. · Healthcare
Director Stephen A. Tullman bought $442K of Aclaris Therapeutics, Inc.
Bought$441,618
$16.54Price
26,700Shares
+5%Stake
What ACRS did for a copier
Prices for ACRS after this filing aren't in yet.
Stephen A. Tullman's record
3 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Apr 6. Filed Mon, Apr 9, 12:50 PM ET, during the session. Not investment advice.